Company / Return on Assets (ROA)
Gossamer Bio, Inc. Return on Assets (ROA) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-98.9%
FY2025
5-year range
-98.9% / -17.9%
FY2021-FY2025
Trend
-451.6%
vs FY2024
Sector context
#208 of 213
Health Care
What the data says
Return on Assets (ROA) changed -452% YoY in FY2025, a notable deviation from the 7-year average annual change of -57%.
Based on SEC 10-K filings.
-98.9% in FY2025 with a 5-year CAGR of -53.8%.
Declined from -57.6% to -98.9% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -14.7pp
- 5-Year Change
- -53.8pp
- 10-Year Change
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 213This company -98.9% Sector average -24.1%
▼
-309.7% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 451.6% year-over-year.
- Currently 74.8pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -9.62 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -98.9% | -451.6% |
| FY2024 | -17.9% | +68.9% |
| FY2023 | -57.6% | +31.5% |
| FY2022 | -84.2% | -23.6% |
| FY2021 | -68.1% | -50.9% |
| FY2020 | -45.1% | -6.7% |
| FY2019 | -42.3% | +31.1% |
| FY2018 | -61.4% | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026